메뉴 건너뛰기




Volumn 371, Issue 8, 2014, Pages 775-776

More blood for sickle cell anemia?

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA;

EID: 84907353675     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1405776     Document Type: Editorial
Times cited : (7)

References (10)
  • 1
    • 84907010836 scopus 로고    scopus 로고
    • Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
    • DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med 2014;371:699-710.
    • (2014) N Engl J Med , vol.371 , pp. 699-710
    • DeBaun, M.R.1    Gordon, M.2    McKinstry, R.C.3
  • 3
    • 77952297450 scopus 로고    scopus 로고
    • Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia
    • Vichinsky EP, Neumayr LD, Gold JI, et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010;303:1823-31.
    • (2010) JAMA , vol.303 , pp. 1823-1831
    • Vichinsky, E.P.1    Neumayr, L.D.2    Gold, J.I.3
  • 4
    • 84886874276 scopus 로고    scopus 로고
    • High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors
    • Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062-71.
    • (2013) Blood , vol.122 , pp. 1062-1071
    • Chou, S.T.1    Jackson, T.2    Vege, S.3    Smith-Whitley, K.4    Friedman, D.F.5    Westhoff, C.M.6
  • 5
    • 84864153894 scopus 로고    scopus 로고
    • Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management
    • Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120:528-37.
    • (2012) Blood , vol.120 , pp. 528-537
    • Yazdanbakhsh, K.1    Ware, R.E.2    Noizat-Pirenne, F.3
  • 6
    • 29544444495 scopus 로고    scopus 로고
    • Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease
    • DOI 10.1056/NEJMoa050460
    • Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769-78. (Pubitemid 43016816)
    • (2005) New England Journal of Medicine , vol.353 , Issue.26 , pp. 2769-2778
    • Adams, R.J.1    Brambilla, D.2
  • 7
    • 0029025475 scopus 로고
    • Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
    • Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
    • (1995) N Engl J Med , vol.332 , pp. 1317-1322
    • Charache, S.1    Terrin, M.L.2    Moore, R.D.3
  • 9
    • 79955909191 scopus 로고    scopus 로고
    • Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG)
    • Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011;377:1663-72.
    • (2011) Lancet , vol.377 , pp. 1663-1672
    • Wang, W.C.1    Ware, R.E.2    Miller, S.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.